Revance Therapeutics, Inc. (RVNC)

Revance Therapeutics Revenue

Revance Therapeutics had revenue of $59.88M in the quarter ending September 30, 2024, with 10.66% growth. This brings the company's revenue in the last twelve months to $256.95M, up 25.82% year-over-year. In the year 2023, Revance Therapeutics had annual revenue of $234.04M with 76.55% growth.

• Revenue (ttm): $256.95M
• Revenue Growth: +25.82%
• P/S Ratio: n/a
• Revenue / Employee: $430,394
• Employees: 597
• Market Cap: 383.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	234.04M	101.48M	76.55%
Dec 31, 2022	132.57M	54.77M	70.40%
Dec 31, 2021	77.80M	62.47M	407.65%
Dec 31, 2020	15.33M	14.91M	3,610.65%
Dec 31, 2019	413.00K	-3.32M	-88.92%